STRATA Skin Sciences Inc announces the publication of an independent study on the treatment of vitiligo using the Company’s XTRAC excimer laser.
A nationwide phase II clinical trial, coordinated out of Tufts Medical Center in Boston, has found that a topical cream was extremely effective in reversing the effects of vitiligo, a relatively common autoimmune disease that causes loss of skin pigmentation.Read More
Scientists can now repurpose fibroblasts into functional melanocytes. The new technique may hold immediate and important implications for treating vitiligo and screening for melanoma.Read More
Combination therapy with afamelanotide and NB-UV-B phototherapy may help vitiligo patient achieve faster repigmentation than NB-UV-B alone, a new study shows.Read More